This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here Are the Factors Influencing Aaron's (AAN) Q3 Earnings
by Zacks Equity Research
Despite the continuity of the COVID-19 outbreak-related woes, strength in the Progressive segment, solid online sales and a robust lease portfolio are likely to have aided Aaron's (AAN) Q3 results.
CVS Health (CVS) Stock Moves -1.15%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $59.56 in the latest trading session, marking a -1.15% move from the prior day.
Zacks Industry Outlook Highlights: CVS, Walgreens Boots, Rite Aid, Amazon and Herbalife
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS, Walgreens Boots, Rite Aid, Amazon and Herbalife
2 Top Retail Pharmacy and Drug Store Stocks to Beat Volatility
by Urmimala Biswas
Social-distancing measures to combat coronavirus have dented demand for Retail Pharmacy and Drug Store industry, casting a shadow on its outlook. Industry participants like CVS and HLF however seem to be in a position to tide over the situation.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity
by Zacks Equity Research
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $59.43 in the latest trading session, marking a +1.11% move from the prior day.
Pick These 5 Stocks With Superb Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Meritage Homes (MTH), Vertex Pharmaceuticals (VRTX), CVS Health (CVS), Amedisys (AMED) and Insperity (NSP) are sound enough to meet financial obligations.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $58.51, moving -1.03% from the previous trading session.
UnitedHealth Expands Offers to Tap Medicare Advantage Market
by Zacks Equity Research
UnitedHealth's (UNH) Medicare Advantage expansion in new counties and states with attractive price and a slew of product and service offerings to grow its market share.
Evaluating Struggling Walgreens (WBA) Stock Ahead of Q4 Earnings
by Benjamin Rains
Walgreens Boots Alliance (WBA) hasn't gained any sustained momentum during the market comeback, with the stock down 37% in 2020, against the S&P 500's 8% jump...
Is CVS Health (CVS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - October 06, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $58.95 in the latest trading session, marking a +1.94% move from the prior day.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $57.54 in the latest trading session, marking a -0.69% move from the prior day.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - September 29, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
CVS Health (CVS) Stock Moves -1.27%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $57.40, marking a -1.27% move from the previous day.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - September 21, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $58.41, marking a +1.62% move from the previous day.
The Zacks Analyst Blog Highlights: Walmart, Oracle, Sanofi, Amazon, GlaxoSmithKline and CVS Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walmart, Oracle, Sanofi, Amazon, GlaxoSmithKline and CVS Health
CVS Health Retail Prescription Volume Grows Despite LTC Woes
by Zacks Equity Research
CVS Health's (CVS) consumer centric digital strategy has become even more relevant now.
Top Analyst Reports for Walmart, Oracle & Sanofi
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT), Oracle (ORCL) and Sanofi (SNY).
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - September 14, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - September 14, 2020
by Zacks Equity Research
Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.